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1. Introduction
Multifunctional nanocarriers integrating the properties of bioim-
aging, targeting, and stimuli-responsive release of guest mole-
cules allow a spatiotemporal controlled delivery and tracking 
of therapeutics, which is the prime prerequisite for in vivo 
Core–shell nanocapsules are receiving increasing interest for drug delivery 
applications. Silica nanocapsules have been the focus of intensive studies due to 
their biocompatibility, versatile silica chemistry, and tunable porosity. However, a 
versatile one-step preparation of silica nanocapsules with well-defined core–shell 
structure, tunable size, flexible interior loading, and tailored shell composition, 
permeability, and surface functionalization for site-specific drug release and 
therapeutic tracking remains a challenge. Herein, an interfacially confined sol–gel 
process in miniemulsion for the one-step versatile preparation of functional silica 
nanocapsules is developed. Uniform nanocapsules with diameters from 60 to 
400 nm are obtained and a large variety of hydrophobic liquids are encapsulated 
in the core. When solvents with low boiling point are loaded, subsequent solvent 
evaporation converts the initially hydrophobic cavity into an aqueous environ-
ment. Stimuli-responsive permeability of nanocapsules is programmed by intro-
ducing disulfide or tetrasulfide bonds in the shell. Selective and sustained release 
of dexamethasone in response to glutathione tripeptide for over 10 d is achieved. 
Fluorescence labeling of the silica shell and magnetic loading in the internal 
cavity enable therapeutic tracking of nanocapsules by fluorescence and electron 
microscopies. Thus, silica nanocapsules represent a promising theranostic nano-
platform for targeted drug delivery applications.
Dr. S. Jiang, M. Mottola, S. Han, Dr. R. Thiramanas, Dr. R. Graf,  
Dr. I. Lieberwirth, Prof. V. Mailänder, Prof. D. Crespy, Prof. K. Landfester
Max Planck Institute for Polymer Research




Cátedra de Química Biológica
Facultad de Ciencias Exactas
Físicas y Naturales
Universidad Nacional de Córdoba
Av. Vélez Sársfield 1611, X5016GCA Córdoba, Argentina
The ORCID identification number(s) for the author(s) of this article 
can be found under https://doi.org/10.1002/ppsc.201900484.
M. Mottola
CONICET
Instituto de Investigaciones Biológicas y Tecnológicas (IIBYT)
Av. Vélez Sarsfield 1611, X5016GCA Córdoba, Argentina
Prof. V. Mailänder
Dermatology Clinic
University Medical Center of the Johannes Gutenberg-University
Langenbeckstr. 1, 55131 Mainz, Germany
Prof. D. Crespy
Max Planck-VISTEC Partner Laboratory for Sustainable Materials
Department of Materials Science and Engineering
School of Molecular Science and Engineering
Vidyasirimedhi Institute of Science and Technology (VISTEC)
Rayong 21210, Thailand
nanocarrier-mediated drug delivery.[1–4] 
Driven by the rapid progress in their syn-
thetic control, mesoporous silica nanoma-
terials have attracted increasing attention 
due to their large specific surface area, 
tunable pore volume and structure, and 
facile surface modification, thus showing a 
wide application prospect for drug delivery 
and biomedicine.[5–15] Compared with 
mesoporous silica nanoparticles with a solid 
core, core–shell silica nanocapsules (SiO2 
NCs) have the advantages that their interior 
cavity offers a large loading capacity for guest 
molecules and the shell can be designed to 
display a tunable permeability for specific 
cargo release.[16] In spite of recent progress 
in nanocapsules design, a versatile approach 
for the preparation of functional SiO2 NCs 
for biomedical applications with control at 
morphological and molecular levels, e.g., the 
core–shell structure, tunable size, interior 
contents, and the shell composition, perme-
ability, and surface functionalization, is still 
needed.
Hard-templating approaches are often 
used for preparing SiO2 NCs as they typically result in well-
defined size and shape.[17] For example, redox-triggered biode-
gradable NCs with disulfide-bridged silsesquioxane frameworks 
were synthesized by using poly(acrylic acid) nanoaggregates[18] 
and silica nanoparticles[19] as templates, which were subse-
quently removed. The payloads were postloaded in the hollow 
© 2020 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, 
Weinheim. This is an open access article under the terms of the Creative 
Commons Attribution License, which permits use, distribution and repro-
duction in any medium, provided the original work is properly cited.
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capsules by adsorption. This strategy often results in low loading 
efficiency and initial burst release especially for water-soluble 
molecules.[16,20,21] Alternatively the payloads can be predissolved 
or adsorbed in the template material. Nonetheless, this approach 
takes several steps and the loading efficiency of guest molecules 
relies highly on their adsorption to the template nanoparticles.[16]
Emulsion-based approaches have been widely studied for the 
encapsulation of payloads in nanocapsules. Guest molecules 
or particles are first dissolved or dispersed in template liquid 
droplets, followed by the formation of a surrounding silica 
shell. A range of materials with different sizes and polarities, 
such as enzymes,[22,23] corrosion inhibitors,[24,25] self-healing 
agents,[26] agrochemicals,[27,28] therapeutic agents,[29,30] imaging 
probes,[31,32] and organic dyes[29,33] were encapsulated in SiO2 
NCs by using water-in-oil or oil-in-water emulsions.[16] Cationic 
surfactants, such as cetyltrimethylammonium bromide and 
chloride were often used as templating agents for confining 
silica formation at droplets interface.[24–26] Wibowo et al. devel-
oped a biomimetic templating technique by designing a dual 
functional peptide by modularizing a surface-active sequence 
capable of stabilizing oil droplets in water with another 
sequence for catalyzing biosilicification at oil–water inter-
faces.[27] This biomineralizing peptide enabled the formation of 
SiO2 NCs at near-neutral pH value and ambient temperature. 
However, the large scale production of complex peptides is a 
limiting factor.[34,35] Jakhmola et al. synthesized SiO2 NCs via a 
biosilicification process induced by poly(l-lysine) immobilized 
on the surface of emulsion droplets.[36] This synthetic process 
requires several steps. First, a central oil core was stabilized by 
a lecithin surfactant, followed by the adsorption of positively 
charged poly(l-lysine) on the droplets. Afterward, negatively 
charged silica species were attached onto nanodroplets and 
formed a silica shell. Erni et al. synthesized microcapsules with 
dense walls composed entirely of a biopolymer scaffold inter-
penetrated with amorphous silica.[37] A weakly acidic hydrogel 
shell was first formed around oil droplets, which then served 
as a scaffold to induce protein-directed mineralization of silica. 
The precipitation process, occurring in the hydrogel scaffold, 
consumed water to form silica, yielding dense shells with a 
very low permeability for volatile organic compounds. How-
ever, the diameter of capsules was hundreds of μm, which is 
out of the applicability range for in vivo drug delivery via intra-
venous administration (>>5 μm).[38] Although these synthetic 
approaches were successful, effective, and versatile synthetic 
approaches that are independent of customized templating 
agents and avoid multiple steps are still needed to prepare well-
defined SiO2 NCs for biomedical applications.
In this study, we developed a one-step approach for versatile 
preparation of functional SiO2 NCs for biomedical applications. 
The SiO2 NCs were synthesized via a confined sol–gel process 
at the nanodroplet-water interface of oil-in-water miniemul-
sions (Figure 1a). By this approach, a versatile synthesis of SiO2 
NCs with morphological and molecular control was achieved, 
including a defined core–shell structure, tunable size, flexible 
interior loading, and tailored shell composition, permeability, 
and surface functionalization. These features allow site-specific 
drug release and enable therapeutic tracking of labeled SiO2 
NCs by fluorescence and electron microscopic techniques.
Part. Part. Syst. Charact. 2020, 1900484
Figure 1. Schematic illustration for: a) The preparation of silica nanocapsules dispersed in water. The initially hydrophobic core can be converted to 
an aqueous core. b) Features of the silica nanocapsules offered by this synthetic procedure.
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2. Results and Discussion
The SiO2 NCs were synthesized via a confined sol–gel process 
at the nanodroplets-water interface in an oil-in-water minie-
mulsion. The oil phase forming the nanodroplets consisted in 
a mixture of silica precursors, osmotic pressure agent, organic 
solvent, and functional payloads to be encapsulated. This hydro-
phobic mixture was subsequently dispersed in an aqueous solu-
tion of surfactant by ultrasonication (see Figure 1a). By this 
approach, therapeutic agents were directly encapsulated in the 
liquid core of nanocapsules during the shell formation. Simul-
taneously, functional silica precursors, i.e., alkoxysilanes con-
taining amino groups, fluorescent probes, or redox-responsive 
disulfide bonds, can be integrated in the silica shell to achieve 
multiple control for the morphology, cargo loading, shell com-
position, and functionality in one step.
2.1. Control of the Core–Shell Structure by Interfacially  
Confined Silicification
Cetyltrimethylammonium chloride (CTMA-Cl) was used here 
as a cationic surfactant to stabilize the miniemulsion drop-
lets against coalescence. More importantly, the second role 
of CTMA-Cl is to serve as templating agent for confining the 
condensation of hydrolyzed silica precursors at oil/water inter-
face via cooperative self-assembly of negatively charged silica 
species and cationic surfactant, hence avoiding secondary 
nucleation of silica in the continuous phase (Figure 2a).[16] This 
electrostatic interaction results from the dissociation of silanol 
groups at experimental pH (4-5), which is above the isoelectric 
point of silica (≈pH 2–3).[39] To demonstrate the templating 
effect generated by CTMA-Cl, we used the nonionic surfactant 
Lutensol AT50 to fully or partially replace CTMA-Cl (Table S1, 
Supporting Information). When the nonionic surfactant was 
used without CTMA-Cl, no capsules were observed by trans-
mission electron microscopy (TEM). Only small nanoparticles 
were observed (Figure 2b), indicating a noncontrolled nuclea-
tion of silica in the continuous phase (Figure 2a). Precipitation 
of white solids was observed after 24 h storage without stirring 
(Figure S1a, Supporting Information). When CTMA-Cl was 
introduced, nanocapsules with defined core–shell structure 
were observed by TEM (Figure 2c–f). Core–shell nanocap-
sules were formed at 10% CTMA-Cl. However, gelation of the 
dispersion was observed after 24 h of storage without stirring 
(Figure S1b, Supporting Information), which suggests an insuf-
ficient confinement of silanol condensation at the droplets’ 
interface. Remarkably, the dispersions were stable when ≥25% 
CTMA-Cl were used (Figure S1c–e, Supporting Information). 
The size of the nanocapsules were smaller with increasing 
amount of CTMA-Cl (Table S1, Supporting Information), which 
is attributed to the generally higher stabilizing efficiency of low 
molecular weight cationic surfactants compared with nonionic 
surfactants.[40]
2.2. Controlling the Size of the Nanocapsules
The size of drug delivery nanocarriers influences their in 
vivo pharmacokinetics, including cellular uptake, biodis-
tribution, and circulation half-life of nanoparticles.[41] In 
miniemulsion polymerization, the particle size can be varied 
in a wide range mainly by changing the type and amount 
of surfactant. Other factors, such as the volume ratio of 
Part. Part. Syst. Charact. 2020, 1900484
Figure 2. a) Schematic illustration of the confined interfacial silicification process templated by CTMA-Cl. b–f) TEM micrographs of nanocapsules 
stabilized by mixtures of CTMA-Cl and Lutensol AT50 with nCTMA-Cl:nLutensol molar ratio of b) 0:1 (sample SJP120a), c) 1:22.7 (sample SJP120b), d) 1:7.6 
(sample SJP120c), e) 1:2.5 (sample SJP120d), and f) 1:0 (sample SJP120f).
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dispersed phase to continuous phase, energy input, and 
electrolyte concentration of the aqueous phase can also play 
a role on the particle size.[40] To obtain nanocapsules with 
a narrow size distribution, an osmotic agent acting as cos-
tabilizer is essential for hindering Ostwald ripening of the 
nanodroplets. Hexadecane was used here due to its very low 
solubility in water.[42]
SiO2 NCs with a tunable average hydrodynamic diameter 
ranging from 60 to 400 nm were synthesized. The other 
parameters were kept constant (Table S2, Supporting Infor-
mation). As the oil/water volume ratio decreased from 40%, 
20%, 10%, to 5%, the corresponding average hydrodynamic 
diameters decreased from 395, 147, 103, to 59 nm, respectively. 
All nanocapsules displayed well-defined core–shell structures, 
as shown by TEM in Figure 3. Increasing the concentration 
of the surfactant from 0.8 to 1.6 g L−1 led to remarkably small 
capsules with an average size of 45 nm (TEM micrographs in 
Figure S2, Supporting Information). The shell thickness can 
be increased by increasing the concentration of alkoxysilane 
in the dispersed phase and by controlling the ratio between oil 
and water. The corresponding shell thickness (d) are provided 
in Figure 3. As the hydrodynamic diameter of nanocapsule 
decreases from 395 to 59 nm, the shell thickness decreased 
accordingly from 17 to ≈4 nm.
2.3. Toward Bioinspired Compartmentalization
To generalize the nanocapsule formation for an effective 
loading of diverse payloads, a variety of hydrophobic liquids 
was used to form the core of SiO2 NCs (Table S3, Supporting 
Information). Nanocapsules with defined core–shell structure 
(Figure 4) and a diameter of ≈100–200 nm (Table S3, Sup-
porting Information) were formed with various organic 
solvents. In the following study, we chose olive oil as a rep-
resentative biocompatible solvent and chloroform as low 
boiling point solvent to form the core of NCs. In the latter 
case, chloroform could be evaporated after silica formation 
by diffusion through the aqueous continuous phase[43] and 
water filled the interior cavity of the NCs (Figure 1a). Thus, 
an oil–water core exchange process was carried out. Aqueous 
dispersions of water-filled nanocapsules were directly 
obtained in one pot, which mimics the biological cell mem-
branes and intracellular compartments that display aqueous 
interiors. Usually, the synthesis of aqueous dispersions of 
nanocapsules with an aqueous core requires two steps: i) The 
capsule formation in inverse (water-in-oil) miniemulsions, 
and ii) the subsequent transfer in aqueous media and stabi-
lization with an additional surfactant with high hydrophilic-
lipophilic balance value. The organic solvent is evaporated 
afterward.[44,45]
The NCs prepared from olive oil and chloroform (the latter 
followed by solvent evaporation) here are denoted as NCoil 
and NCwater, respectively. The evaporation of chloroform was 
evidenced by the disappearance of its characteristic signal at 
7.26 ppm in 1H NMR spectra after 12 h (Figure S3, Supporting 
Information). As shown in Figure 5, a well-defined core–shell 
morphology of SiO2 NCs was identified by TEM, indicating the 
successful condensation of alkoxysilane around the miniemul-
sion droplets. The average diameters determined in the dried 
state by scanning electron microscopy (SEM) were 34 ± 23 nm 
for NCoil and 58 ± 28 nm for NCwater. Their corresponding 
average shell thicknesses were 4.5 ± 1.8 and 4.4 ± 1.9 nm, as 
determined from TEM micrographs.
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Figure 3. TEM micrographs of SiO2 NCs with hydrodynamic diameter Dh controlled by tuning the oil/water volume ratio. a) Dh = 395 nm, d (shell thick-
ness) ≈17 ± 4 nm, Voil/Vwater = 40% (sample SJP45-0), b) Dh = 147 nm, d ≈ 8 ± 2 nm, Voil/Vwater = 20% (sample SJP45-1), c) Dh = 103 nm, d ≈ 5 ± 2 nm, 
Voil/Vwater = 10% (sample SJP45-2), and d) Dh = 59 nm, d ≈ 4 ± 2 nm, Voil/Vwater = 5% (sample SJP45-3).
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2.4. Controlled Release of Payloads
Site-specific release of drug molecules is the prime prerequisite 
for in vivo nanocarrier-mediated drug delivery. Controlled drug 
release can be achieved by preparing shells so that their perme-
ability change in response to local conditions of target tissues. 
Here, we show that nanocapsules can be designed to selectively 
release the drug dexamethasone (DXM) in response to the pres-
ence of glutathione tripeptide (GSH). DXM is a hydrophobic 
glucocorticoid used to modulate the inflammatory response of 
liver macrophages. Systemic administration of glucocorticoids 
is associated with severe side-effects, such as hyperglycemia, 
hypertension, and intestinal bleeding.[46] Therefore, formu-
lating DXM for its intracellular delivery and site-specific release 
is necessary. The fact that glutathione-responsive nanocarriers 
can be used for targeted intracellular drug delivery is based on 
two aspects. i) Many therapeutics (e.g., anticancer drugs, such 
as doxorubicin and paclitaxel, photosensitizers, and antioxi-
dants) and biotherapeutics (e.g., peptides, proteins, and siRNA) 
exert therapeutic effects only inside cells, such as cytosols or 
cell nuclei. ii) Some intracellular compartments, such as the 
cytosol, mitochondria, and cell nuclei contain a significantly 
higher concentration (about 2–10 × 10−3 m) of glutathione trip-
eptides than their concentration in the extracellular and circula-
tion fluids (about 2–20 × 10−6 m).[47]
To this purpose, we introduced disulfide and tetrasulfide link-
ages into the silica shell of nanocapsules by using alkoxysilanes 
containing di-/tetrasulfide bonds as precursor for building the 
Part. Part. Syst. Charact. 2020, 1900484
Figure 4. SEM micrographs of SiO2 NCs synthesized with different hydrophobic liquids as oil core: a) oleic triglyceride (sample SJP16-0), b) Miglyol 
812N (sample SJP16-1), c) m-xylene (sample SJP1), d) hexadecane (sample SJP16-2), e) cyclohexane (sample SJP16-4), and f) dichloromethane 
(sample SJP82-0).
Figure 5. Scheme, SEM, and TEM micrographs of SiO2 NCoil a–d) and NCwater after the oil–water exchange process e–h).
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silica shell. The resulting nanocapsules were denoted as SiO2 
NC-2S or SiO2 NC-4S, respectively. In order to determine 
the amount of siloxane bridges, silanol groups, and incor-
porated disulfide and tetrasulfide linkages in the silica shell, 
the NC-2S/4S shells were measured by 29Si MAS NMR and 
13C CP-MAS NMR spectroscopy. The 29Si NMR spectra show 
signals at −110 and −100 ppm corresponding to the Q4 and 
Q3 units (Qn: Si(OSi)n(OH)4−n), respectively (Figure S4, Sup-
porting Information). The high percentage of Q4 signal 
(Q4 > 55% for control samples and Q4 ≥ 85% for all hybrid cap-
sules) confirmed the successful formation of silica network by 
siloxane bridges (Table 1). Compared with NCoil, the percentage 
of Q4 signal of NCs filled with water increased slightly, indicating 
that the alkoxysilanes were further hydrolyzed when the core was 
exchanged with water. Moreover, the percentage of Q4 signal is 
also related to the permeability of the silica shell. When the Q4 
signal increased from 56% for control NCs to 85% for NCoil-
2S-25%, the encapsulation efficiency of DXM increased over 
50% owing to the higher crosslinking degree of the silica shell. 
The absence of free (Q0) and monoreacted alkoxysilane (Q1), 
and very low resonance corresponding to Q2 (1% for NCoil and 
3% for NCwater) showed that the alkoxysilanes were efficiently 
reacted. The signals at −68 and −58 ppm originated from the 
T3 and T2 units of the alkoxysilanes containing sulfide groups 
(Tm: CSi(OSi)m(OH)3−m), respectively (Figure S4, Supporting 
Information). The T signals together with 13C signals at 12.1, 
23.3, and 41.8 ppm corresponding to the 1C, 2C, and 3C in 
the series of Si-1C-2C-3C-S-S-3C-2C-1C-Si, respectively, proved 
the integration of the sulfide-containing alkoxysilanes within the 
SiO2 shell, forming an organic–inorganic hybrid silsesquioxane 
framework. T0 signal indicated uncondensed functional alkox-
ysilanes, probably due to their higher hydrophobicity compared 
with tetraethoxysilane (TEOS). To confirm this hypothesis, we 
incubated pure bis(triethoxysilylpropyl)disulfide in CTMA-Cl 
aqueous solution under experimental condition. After stirring 
at 500 rpm for 7 d, a strong T0 signal (74% compared to Tn 
signals) was measured. In parallel, freeze-dried powder of the 
sample NCwater-2S-25% was extracted repeatedly with ethanol. 
By this washing step, T0 signal of the sample was significantly 
reduced from 77% to 24% (Table S4 and Figure S4h, Supporting 
Information). Both experiments showed the partial conversion 
of functional alkoxysilanes under the experimental conditions. 
The size distribution and zeta potential of SiO2 NCs after incor-
porating the functional alkoxysilanes are listed in Table 1. The 
NCs measured here were stabilized by the nonionic surfactant 
Lutensol AT50 and therefore their surface charges were close 
to neutral. As a comparison, SiO2 NCs stabilized by a cationic 
surfactant CTMA-Cl were positively charged (e.g., zeta poten-
tial was +12 mV for SiO2 NCoil). In addition, nanocapsules syn-
thesized with chloroform as solvent were uniform when TEOS 
was used as sole silica precursor (Figure 5f–h). The size and 
polydispersity of NCs increased as the content of functional 
alkoxysilanes bis(triethoxysilylpropyl) disulfide (TESPD) and 
bis[3-(triethoxysilyl) propyl] tetrasulfide (TESPT) increased from 
0% to 50% (Figure S5, Supporting Information).
In vitro glutathione-responsive release of DXM from SiO2 
NCs was studied by incubating purified nanocapsules in an 
aqueous medium containing 10 × 10−3 m GSH, which is com-
monly used to mimic the reducing intracellular microenviron-
ment.[18,48,49] The GSH-responsive release mechanism is shown 
in Figure 6a.
Dispersions of SiO2 NCs were incubated in the absence 
of GSH for control experiments. As shown in Figure 6c, less 
than 5% DXM was released within 15 d for all NCoil-2S/4S. In 
the presence of GSH in the incubation medium (10 × 10−3 m), 
the release of DXM from NCoil-2S-25% was dramatically 
Part. Part. Syst. Charact. 2020, 1900484
Table 1. Hydrolysis degree of the emulsified alkoxysilanes, hydrodynamic diameters Dh, zeta potential ξ, and encapsulation efficiency of DXM after 
dialysis of the silica nanocapsules.
Entry Silica precursors Content of Qn and Tn sites [%]a) Dh [nm] ξb) [mV] EE [%]
Q2 Q3 Q4 T0 T1 T2 T3
NCoil 1 43 56 — — — — 179 ± 53 −2 ± 1 38
NCwater 3 41 56 — — — — 115 ± 55 −1 ± 1 39
NCoil-2S-25% 0 15 85 34 1 29 36 157 ± 54 −1 ± 1 58
NCoil-2S-50% 0 15 85 76 2 10 12 169 ± 22 2 ± 1 60
NCwater-2S-25% 0 11 89 77 2 10 11 193 ± 38 −2 ± 1 45
NCwater-2S-50% 0 14 86 72 2 15 11 223 ± 118 −2 ± 1 —
NCoil-4S-25% 0 25 75 30 2 38 30 175 ± 74 1 ± 1 25
NCwater-4S-25% 0 14 86 64 2 27 7 210 ± 65 −4 ± 1 36
a)Freeze-dried prior to the measurements; b)Zeta potential of SiO2 NCs stabilized by the nonionic surfactant Lutensol AT50.
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accelerated due to the cleavage of disulfide linkages that led 
to an increase of the permeability of the silica shell.[50] Both 
increasing the content of disulfide bonds or replacing disulfide 
by tetrasulfide bonds further increased the released amount of 
DXM at equilibrium (Figure 6c). No obvious differences were 
observed for the release profiles of nanocapsules with olive 
oil or water as the filling liquids (Figure 6c,d). Moreover, the 
GSH-responsive release profiles of DXM from SiO2 NCs dis-
play a sigmoidal shape which is a unique feature and avoids 
the burst release of other release systems. Indeed, there were 
two diffusion processes taking place in the release system. 
First, GSH tripeptides are required to diffuse through the silica 
shell and cleave the disulfide linkages. Therefore, a relatively 
slow release was observed in the initial stage. As the amount of 
disulfide cleavage increased, the release was accelerated due to 
the increased permeability of the silica shell. This yields a sus-
tained release of therapeutic payloads up to over 10 d.
The change in the permeability of the silica shell during the 
release process was investigated by nitrogen adsorption–des-
orption experiments. The pore size distribution of NCoil-2S 
shifted to larger values due to the cleavage of disulfide linkages 
after incubation with 10 × 10−3 m GSH for 15 d (Figure 6b). 
Compared to NCoil-2S before incubation, a new peak corre-
sponding to pores with sizes ≈7–8 nm in width appeared for 
the reduced nanocapsules. The increase in the porosity of the 
silica shell after reduction is consistent with the specific release 
profiles of DXM in response to GSH. The core–shell structure 
was kept intact after release because the silica network formed 
by silicium oxide bonds remain, while the disulfide bonds are 
opened.[25]
2.5. Control of Nanocapsule Functionalization
The core–shell structure allows flexible functionalization of 
nanocapsules by postfunctionalizing the outer surface, incor-
porating functional building blocks in precursors forming 
the shell, or via encapsulation in the interior cavity. Fluores-
cent dye Cyanine5 (Cy5) was covalently integrated in the silica 
shell by copolymerization. The presence of the dye is impor-
tant for quantifying cellular uptake of NCs in CD8+ T-cells by 
flow cytometry and visualizing the cell uptake process under 
confocal laser scanning microscopy (cLSM). After 24 h incuba-
tion, SiO2 NCs showed good biocompatibility toward T-cells at 
nanocapsule concentrations up to 80 μg mL−1 (Figure 7a). Over 
90% cells were Cy5 positive cells at NC concentration from 
20 to 80 μg mL−1, indicating a good cellular uptake of NCs by 
CD8+ T-cells (Figure 7b). NCs were colocalized with lysosomes 
(Figure 7c–f), which is a solid proof of cellular uptake. High cell 
viability and uptake were also found for Jurkat and Hela cells as 
shown in Figures S6 and S7 (Supporting Information).
TEM provides higher resolution imaging for investigating 
cellular uptake and intracellular trafficking of nanocarriers. 
However, core–shell nanocapsules have a size and morphology 
that are similar to cellular organelles. Therefore, both types 
of compartments are difficult to distinguish. To overcome 
Part. Part. Syst. Charact. 2020, 1900484
Figure 6. a) Schematic illustration of GSH-responsive release of DXM from SiO2 NC-2S. b) Pore size distribution of SiO2 NC-2S before and after 
reduction by GSH. Release profiles of DXM from c) SiO2 NCoil and d) SiO2 NCwater containing various amounts of disulfide or tetrasulfide bonds in the 
shell. The open and solid symbols correspond to the samples incubated without (control) and with 10 × 10−3 m GSH in the medium, respectively. The 
DXM loading amount in the SiO2 NCs was determined based on the encapsulation efficiency of DXM and the solid content of nanocapsule disper-
sions. The loading contents are 23.3 μg DXM mg−1 NC for SiO2 NCoil 2S-25%, 16.6 μg mg−1 for SiO2 NCoil 2S-50%, 6.0 μg mg−1 for SiO2 NCoil 4S-25%, 
20.2 μg mg−1 for SiO2 NCwater 2S-25%, and 13.7 μg mg−1 for SiO2 NCwater 4S-25%.
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this issue, we loaded SiO2 NCs with iron oxide nanoparticles 
(Fe3O4 NPs), which provided a higher contrast and also allowed 
the localization of NCs by monitoring elemental distribu-
tion of silicon and iron. As shown in the TEM micrographs 
in Figure 8a–c, various amounts of iron oxide can be encap-
sulated in NCs (Table S5, Supporting Information). By encap-
sulating Fe3O4 NPs as contrast agent, SiO2 NCs were clearly 
distinguished from cellular organelles (Figure 9). Combined 
with elemental mapping of silicon and iron obtained by elec-
tron energy loss spectroscopy (EELS, Figure 9c) and energy 
dispersive X-ray spectroscopy (EDS, Figure 9d), cellular uptake 
of nanocapsules and their localization in intracellular environ-
ment were successfully confirmed (Figure 9e). Superparamag-
netism of Fe3O4 NPs was preserved after the encapsulation, 
with a saturated magnetization of 10.0 emu g−1 nanocapsules 
(Figure 8d). Therefore, the magnetic NCs are also potentially 
useful for magnetic resonance imaging and magnetic-guided 
targeted delivery.
3. Conclusions
We demonstrated here a versatile one-step synthesis of SiO2 
NCs for biomedical applications. This approach is based on a 
sol–gel process confined at the interface of oil-in-water minie-
mulsion droplets. Hydrodynamic diameters of NCs could be 
controlled between 60 and 400 nm. NCs are formed with var-
ious hydrophobic liquids for potentially encapsulating cargos 
with different solubility. Solvents with low boiling point can 
be evaporated to convert the interior cavity to an aqueous envi-
ronment in one pot. By introducing disulfide or tetrasulfide 
bonds in the shell, the SiO2 NCs show a specific and sustained 
release of dexamethasone in response to the presence of glu-
tathione tripeptide for over 10 d. Fluorescent and magnetic 
labeling enable monitoring of cellular uptake and intracellular 
trafficking of the NCs by fluorescence microscopy and TEM 
combined with elemental mapping. These features show that 
the versatile synthetic approach is promising for the con-
trolled preparation of functional SiO2 NCs for drug delivery 
applications.
4. Experimental Section
Materials: TEOS (Alfa Aesar, 98%), TESPD (Gelest, 90%), (TESPT, 
Sigma-Aldrich, 90%), 3-aminopropyltrimethoxysilane (APTES, Alfa 
Aesar, >98%), hexadecane (Sigma-Aldrich, 99%), olive oil (Sigma-
Aldrich, highly refined, low acidity), oleic triglyceride (Sigma-Aldrich, 
≥99%), Miglyol 812N (IOI Oleo), m-xylene (Sigma-Aldrich, ≥99%), 
cyclohexane (Sigma-Aldrich, 99.5%), chloroform (Sigma-Aldrich, ≥99%), 
dichloromethane (Sigma-Aldrich, ≥99.8%), cetyltrimethylammonium 
chloride (CTMA-Cl, Acros Organics, 99%), Lutensol AT50 (BASF), DXM 
(Sigma-Aldrich, ≥98%), and GSH (Appli Chem, ≥97%) were used as 
received. Amine-reactive fluorescent dye Cyanine5 NHS ester (Cy5-NHS) 
was purchased from Lumiprobe GmbH, Germany. Oleic acid capped 
iron oxide nanoparticles (Fe3O4 NPs) were synthesized by a standard 
co-precipitation protocol.[51] Milli-Q water was used throughout the 
synthesis and purification processes of SiO2 NCs.
Synthesis of Silica Nanocapsules: Silica nanocapsules were synthesized 
in an oil-in-water miniemulsion by using the surface of oil nanodroplets 
as template for the hydrolysis and condensation of alkoxysilanes. 
Specifically, 2.0 g (9.6 mmol) of TEOS was first mixed with 125 mg 
of hexadecane and 1 g of organic solvent to form the oil phase. Drug 
(50 mg of DXM, equals to 1.67 mg mL−1 in the dipersion) or iron oxide 
nanoparticles can be dissolved or dispersed in the organic solvent and 
subsequently will be encapsulated in the core of nanocapsules. In the 
second step, 30 mL of 0.77 mg mL−1 aqueous solution of CTMA-Cl was 
poured into the oil mixture under stirring. After a pre-emulsification step 
by stirring at 1000 rpm for 1 h, the obtained emulsion was sonicated 
by using a Branson 450 W sonifier with a 1/2″ tip at 70% amplitude for 
180 s (30 s of sonication, 10 s of pause) with ice cooling. The resulting 
miniemulsion was stirred at 1000 rpm for 12 h at room temperature to 
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Figure 7. Cellular uptake study of Cy5-labeled SiO2 NCs in CD8+ T-cells. a) Cell viability and b) Cy5 positive-cells of CD8+ T-cells after treatment with 
various concentrations of SiO2 NCs for 24 h. cLSM images showing the cellular uptake of SiO2 NCs and colocalization with lysosome in CD8+ T-cells. 
c) The SiO2 NCs were labeled with Cy5 (green), d) lysosomes were stained with LysoTracker Green DND-26 (blue), and e) the cell membranes were 
stained with CellMask Orange (red). f) The merged images of the three channels demonstrated that the NCs were colocalized with lysosomes, as 
indicated with white arrows.
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Figure 8. Characterization of SiO2 NCs loaded with various amounts of iron oxide nanoparticles. TEM micrographs of NCs with miron oxide:msilica = 
a) 1:6.2 (sample SJP29-2), b) 1:2.8 (sample SJP29-3), and c) 1:1.7 (sample SJP29-4). d) VSM magnetization curve of NCs with miron oxide:msilica = 1:2.8.
Figure 9. Intracellular localization of SiO2 NCs labeled with Fe3O4 NPs in Hela cells by TEM and elemental mapping. TEM micrographs of a) SiO2 NCs 
containing Fe3O4 NPs, b) NCs in cells, c) elemental mapping of silicon obtained by EELS, d) elemental mapping of silicon and iron obtained by EDS, 
e) colocalization of NCs based on TEM, EELS, and EDS data.
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obtain an aqueous dispersion of SiO2 NCs. For NCs using chloroform 
as the core liquid, the dispersions were further stirred at 1000 rpm for 
another 12 h without the lids for the vials in order to evaporate the 
chloroform and achieve oil–water exchange for the interior of NCs. In the 
case of nanocapsules containing disulfide or tetrasulfide linkages in the 
shell, a certain amount of TEOS and TESPD/TESPT (in total 9.6 mmol) 
were used as alkoxysilane precursors. For the fluorescent labeling of 
SiO2 NCs, Cy5-NHS was first coupled with APTES at a molar ratio of 
1:1.1 to obtain fluorescently labeled silica precursors. The APTES-Cy5 
conjugates were then mixed with TEOS as the silica source. The molar 
ratio of Cy5 with TEOS was 1:14 000.
Encapsulation Efficiency of DXM: SiO2 NCs were PEGylated by 
exchanging the templating surfactant CTMA-Cl with the nonionic 
surfactant Lutensol AT50. PEGylated nanocapsules were denoted as SiO2 
NC-PEG. Specifically, 35 mg of Lutensol AT50 was added to 2 mL of SiO2 
NCs dispersion. The dispersion was stirred at 1000 rpm for 2 h and then 
dialyzed against water with a dialysis tube with molecular weight cut-off 
(MWCO) of 1000 g mol−1. In this case, CTMA-Cl (Mw = 320 g mol−1) 
could diffuse through the dialysis membrane into the aqueous dialysis 
medium, while Lutensol AT50 (Mw = 2460 g mol−1) was kept inside. 
During the dialysis, the encapsulation efficiency of DXM in NCs was 
determined. The dialysis medium was changed three times per day 
until no DXM could be detected in the supernatant. The concentration 
of nonencapsulated DXM was determined by UV–vis spectroscopy 
(λmax = 243 nm). The encapsulation efficiency of DXM in NCs was 
expressed as the percentage of encapsulated DXM with respect to the 
initial amount of DXM. The calibration curve for the determination 
of DXM in water is shown in Figure S8 (Supporting Information). 
Afterward, the dialyzed dispersion was centrifuged at 10 k rpm to 
remove the excess of Lutensol AT50. The pellet was redispersed in water 
and the dispersion was stirred at 1000 rpm for 24 h.
Glutathione-Responsive Molecular Release from Silica Nanocapsules: 
Stimuli-responsive molecular release from SiO2 NCs was performed 
by dialysis (MWCO of 14 kDa for the membranes). First, 0.3 mL of NC 
dispersion and 0.7 mL of water were placed in a dialysis tube, which 
was then immersed in 30 mL of dialysis medium containing 10 × 10−3 m 
of glutathione. Milli-Q water was used as release medium in control 
experiments. The dialysis system was incubated at 37 °C in a HLC 
thermomixer (MKR 23, Pforzheim, Germany). The concentration of 
released DXM was determined by UV–vis spectroscopy by taking 0.5 mL 
of supernatant from the incubation medium at given intervals. An equal 
volume of fresh incubation medium was added to the release media. 
The release profile of DXM was expressed as cumulative percentage of 
released drug compared to the initial amount of loaded DXM, while the 
effect of dilution was taken into account. The drug release experiments 
were performed in triplicate for each sample.
Cellular Uptake Study by Flow Cytometry: CD8+ T-cells resuspended 
in RPMI cell culture medium containing 1% fetal bovine serum (FBS) 
and 100 U mL−1 IL-2 without antibiotics were added into 0.1 μg mL−1 
of anti-CD3 immobilized 24-well plate at a density of 200 000 cells per 
well. Then, various concentrations of SiO2 NCs were incubated with 
the cells for 24 h. After that, the cells were washed and resuspended in 
PBS. Flow cytometry measurements were performed on a Attune NxT 
Flow Cytometer (Invitrogen, USA). Zombie Aqua dye (BioLegend, USA) 
was used for live cell indicating with the excitation of the violet laser 
(405 nm) and detected in channel VL-2. Cy5 dye labeled NCs were excited 
with red laser (638 nm) and recorded in channel RL-1. Data analysis was 
performed using Attune NxT software (Invitrogen, USA) by selecting the 
cells on a forward/sideward scatter plot, thereby excluding cell debris. 
These gated events were shown by the histogram of fluorescent signal. 
Percentages of cell viability were recorded from living cells (Zombie Aqua 
negative-cells) compared to dead cells (Zombie Aqua positive-cells). After 
gating for living cells, the cells that supposed to take up the SiO2 NCs 
containing Cy5 dye were reported as Cy5 positive-cells.
Cell Imaging by cLSM: To confirm the cellular uptake, CD8+ T-cells 
were treated with the SiO2 NCs as describe above. After that, the 
cells were washed and transferred to μ–Slide 8 well with a glass 
coverslip bottom (Ibidi, Germany). Live cell images were taken with 
a commercial setup (LSM SP5 STED Leica Laser Scanning Confocal 
Microscope, Leica, Germany), consisting of an inverse fluorescence 
microscope DMI 6000 CS equipped with a multilaser combination, 
five detectors operating in the range of 400–800 nm. A HCX PL 
APO CS 63 × 1.4 oil objective was used in this study. LysoTracker 
Green DND-26 (50 × 10−9 m diluted in Dulbecco’s modified Eagle’s 
medium, Life Technologies, USA) was used to stain lysosome for 
1 h, excited with an Ar laser (488 nm), detected at 510–540 nm 
and pseudocolored in blue. The membrane was stained with 
CellMaskOrange and pseudocolored in red. The SiO2 NCs was labeled 
with Cy5 and pseudocolored in green. The merged images of three 
channels demonstrated that the Cy5 labeled SiO2 NCs were colocalized 
with lysosomes as indicated with white arrows.
TEM Analysis: Sapphire disks (3 mm; M. Wohlwend GmbH) were 
precoated with a 10 nm thick carbon layer using an EM MED020 
instrument (Leica). The coated sapphire disks were dried and sterilized 
in an oven at 120 °C overnight before use. HeLa cells were seeded onto 
sapphire disks in 12-well plates overnight for cell attachment. SiO2 NCs 
(loaded with Fe3O4 NPs) were incubated with Hela Cells at 75 μg mL−1 
for 2 h, 10 h, and overnight in a humidified incubator at 37 °C and 5% 
CO2. After the incubation, each sapphire disk was collected from the 
12-well plates and slightly immersed into 1-hexadecene before placing 
them between two aluminum plates (3 mm, Plano). This “sandwich" 
structure was placed into a specimen holder for high pressure freezing 
in a Wohlwend HPF Compact 01 high pressure freezer with a pressure 
of 2100 bar for 2–3 s. The specimen holder was withdrawn from 
the freezer and immersed into liquid nitrogen to release the sample. 
The frozen sample was then labeled and stored in a container filled 
with liquid nitrogen. Subsequently, freeze substitution of the sample 
was carried out in a 0.5 mL Eppendorf tube using an AFS2 automated 
freeze substitution device (Leica). Each tube contained 1 mL of freeze 
substitution solution, consisting of 0.2 wt/vol% osmium tetroxide, 
0.1 wt/vol% uranyl acetate, and 5% distilled water in acetone. The tubes 
were first kept at −90 °C and slowly warmed up to 0 °C in 24 h. After 
keeping at room temperature for 1 h, the substitution solution was 
removed and the samples were washed 3 times with acetone. Each 
sample was infiltrated in an ascending epoxy resin series (30%, 50%, 
and 75% in acetone) for 1 h before finally infiltration in 100% epoxy resin 
overnight. Finally, each sample was transferred into a new Eppendorf 
tube containing freshly prepared pure epoxy resin for polymerization at 
60 °C for 24 h. After polymerization, sample blocks were kept at room 
temperature until their sectioning. Sample blocks for each time point 
were trimmed and sectioned into 100 nm sections by a 45° diamond 
knife (Diatome) in EM UC6 ultramicrotome (Leica). Sections were then 
carefully placed onto 300-mesh copper grid for standard bright-field, 
EELS, and EDS analysis in Tecnai F20 200 kV TEM (FEI). Bright-field 
TEM micrographs were obtained with a Gatan US1000 2k CCD camera. 
EDX images were collected with an EDAX detector.
Characterization of Nanocapsules: Hydrodynamic diameters of SiO2 
NCs were measured by dynamic light scattering with a Nicomp particle 
sizer (Model 380, PSS, Santa Barbara, CA) at a fixed scattering angle 
of 90°. The morphology of nanocapsules was examined with a Gemini 
1530 (Carl Zeiss AG, Oberkochem, Germany) SEM operating at 0.35 kV 
and a Jeol 1400 (Jeol Ltd, Tokyo, Japan) transmission electron microscope 
operating at an accelerating voltage of 120 kV. SEM and TEM samples 
of nanocapsules were prepared by casting the diluted dispersions on 
silicon wafers and carbon layer-coated copper grids, respectively. Surface 
area of nanocapsules was determined from nitrogen adsorption–
desorption experiments carried out on a Quantachrome Autosorb-1 
analyzer (Boynton Beach, FL) at 77.3 K. The capsule dispersions were 
dialyzed against Milli-Q water for 3 d to remove the surfactant. The 
dialyzed dispersions were then freeze-dried for 48 h and degassed at 
70 °C under high vacuum for at least 12 h before measurements. The 
specific surface area was calculated using the Brunauer–Emmett–Teller 
equation based on data points obtained from 0 < P/P0 < 0.25. Zeta 
potential measurements were performed in 10−3 m potassium chloride 
solution at pH 6.8 and 25 °C with a Malvern Zeta sizer (Malvern 
Instruments, UK). Solid content of the capsule dispersion was measured 
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gravimetrically. Quantitative 29Si MAS-NMR spectra were recorded with 
a Bruker Avance II spectrometer operating at 300.23 MHz 1H Larmor 
frequency using a commercial double resonance MAS probe supporting 
MAS rotors with 7 mm outer diameter. Direct excitation spectra were 
acquired with a small excitation angle of ≈20° at 25 kHz rf-nutation 
frequency and 60 s relaxation delay between subsequent transients. 
In order to avoid line broadening due to dipolar couplings, SPINAL64 
hetero-nuclear decoupling at 50 kHz rf-nutation frequency has been 
applied.[52] Typically, 1600–2000 transients with 4096 data points and 
20 μs dwell time have been recorded. The 29Si NMR signals were 
referenced to tetrakis(trimethylsilyl)silane[53] and the assignments of T(n) 
and Q(n) groups were taken from the literature.[54] The content of T(n) 
and Q(n) groups was quantified via deconvolution of the 29Si MAS-NMR 
spectra using the DMfit program by Massiot et al.,[55] because the 
overlapping NMR signals of different T(n) and Q(n) groups could not be 
quantified by integration.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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